WESLEY R ELINGBURG Insider Trading $LH LABORATORY CORP OF AMERICA HOLDINGS
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WESLEY R ELINGBURG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WESLEY R ELINGBURG. WESLEY R ELINGBURG is EVP, CFO, & Treasurer in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and EVP, CFO, and Treasurer in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and EVP, CFO, Treasurer in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and EVP, Chief Financial Officer in LABORATORY CORP OF AMERICA HOLDINGS ($LH).
WESLEY R ELINGBURG in LABORATORY CORP OF AMERICA HOLDINGS
Trading Symbol: LHIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of WESLEY R ELINGBURG: EVP, Chief Financial Officer, EVP, CFO, & Treasurer, EVP, CFO, Treasurer, EVP, CFO, and Treasurer
Holdings: 99,103 shares
Current Value: $12,869,516
Latest Transaction: Mar 18 2004
$LH Market Capitalization: $13.45B
$LH Previous Close: $129.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of WESLEY R ELINGBURG in LABORATORY CORP OF AMERICA HOLDINGS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.50 | 1,382 | 51,825 | 99,103 | 100.5 K to 99.1 K (-1.38 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.51 | 217 | 8,140 | 100,485 | 100.7 K to 100.5 K (-0.22 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.52 | 352 | 13,207 | 100,702 | 101.1 K to 100.7 K (-0.35 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.53 | 2,385 | 89,509 | 101,054 | 103.4 K to 101.1 K (-2.31 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.54 | 271 | 10,173 | 103,439 | 103.7 K to 103.4 K (-0.26 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.55 | 1,571 | 58,991 | 103,710 | 105.3 K to 103.7 K (-1.49 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.56 | 840 | 31,550 | 105,281 | 106.1 K to 105.3 K (-0.79 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.57 | 406 | 15,253 | 106,121 | 106.5 K to 106.1 K (-0.38 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.58 | 109 | 4,096 | 106,527 | 106.6 K to 106.5 K (-0.10 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.59 | 135 | 5,075 | 106,636 | 106.8 K to 106.6 K (-0.13 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.60 | 218 | 8,197 | 106,771 | 107 K to 106.8 K (-0.20 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.62 | 108 | 4,063 | 106,989 | 107.1 K to 107 K (-0.10 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.63 | 135 | 5,080 | 107,097 | 107.2 K to 107.1 K (-0.13 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.64 | 81 | 3,049 | 107,232 | 107.3 K to 107.2 K (-0.08 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.65 | 81 | 3,050 | 107,313 | 107.4 K to 107.3 K (-0.08 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.66 | 271 | 10,206 | 107,394 | 107.7 K to 107.4 K (-0.25 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.67 | 217 | 8,174 | 107,665 | 107.9 K to 107.7 K (-0.20 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.68 | 163 | 6,142 | 107,882 | 108 K to 107.9 K (-0.15 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.69 | 515 | 19,410 | 108,045 | 108.6 K to 108 K (-0.47 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.70 | 461 | 17,380 | 108,560 | 109 K to 108.6 K (-0.42 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.71 | 136 | 5,129 | 109,021 | 109.2 K to 109 K (-0.12 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.72 | 135 | 5,092 | 109,157 | 109.3 K to 109.2 K (-0.12 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.73 | 657 | 24,789 | 109,292 | 109.9 K to 109.3 K (-0.60 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.74 | 407 | 15,360 | 109,949 | 110.4 K to 109.9 K (-0.37 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.76 | 21 | 793 | 110,356 | 110.4 K to 110.4 K (-0.02 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.80 | 162 | 6,124 | 110,377 | 110.5 K to 110.4 K (-0.15 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.87 | 162 | 6,135 | 110,539 | 110.7 K to 110.5 K (-0.15 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.90 | 949 | 35,967 | 110,701 | 111.7 K to 110.7 K (-0.85 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.91 | 54 | 2,047 | 111,650 | 111.7 K to 111.7 K (-0.05 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.95 | 624 | 23,681 | 111,704 | 112.3 K to 111.7 K (-0.56 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.00 | 460 | 17,480 | 112,328 | 112.8 K to 112.3 K (-0.41 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.01 | 244 | 9,274 | 112,788 | 113 K to 112.8 K (-0.22 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.07 | 81 | 3,084 | 113,032 | 113.1 K to 113 K (-0.07 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.10 | 244 | 9,296 | 113,113 | 113.4 K to 113.1 K (-0.22 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.90 | 24,495 | 928,361 | 113,357 | 137.9 K to 113.4 K (-17.77 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.91 | 1,246 | 47,236 | 137,852 | 139.1 K to 137.9 K (-0.90 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.92 | 767 | 29,085 | 139,098 | 139.9 K to 139.1 K (-0.55 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.93 | 244 | 9,255 | 139,865 | 140.1 K to 139.9 K (-0.17 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.94 | 352 | 13,355 | 140,109 | 140.5 K to 140.1 K (-0.25 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.95 | 2,174 | 82,503 | 140,461 | 142.6 K to 140.5 K (-1.52 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.96 | 895 | 33,974 | 142,635 | 143.5 K to 142.6 K (-0.62 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.97 | 598 | 22,706 | 143,530 | 144.1 K to 143.5 K (-0.41 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.98 | 965 | 36,651 | 144,128 | 145.1 K to 144.1 K (-0.67 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 37.99 | 292 | 11,093 | 145,093 | 145.4 K to 145.1 K (-0.20 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.00 | 1,275 | 48,450 | 145,385 | 146.7 K to 145.4 K (-0.87 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.01 | 80 | 3,041 | 146,660 | 146.7 K to 146.7 K (-0.05 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.02 | 81 | 3,080 | 146,740 | 146.8 K to 146.7 K (-0.06 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.03 | 440 | 16,733 | 146,821 | 147.3 K to 146.8 K (-0.30 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.04 | 921 | 35,035 | 147,261 | 148.2 K to 147.3 K (-0.62 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.05 | 319 | 12,138 | 148,182 | 148.5 K to 148.2 K (-0.21 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.06 | 108 | 4,110 | 148,501 | 148.6 K to 148.5 K (-0.07 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.07 | 244 | 9,289 | 148,609 | 148.9 K to 148.6 K (-0.16 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.08 | 27 | 1,028 | 148,853 | 148.9 K to 148.9 K (-0.02 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.09 | 570 | 21,711 | 148,880 | 149.5 K to 148.9 K (-0.38 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.10 | 190 | 7,239 | 149,450 | 149.6 K to 149.5 K (-0.13 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.11 | 183 | 6,974 | 149,640 | 149.8 K to 149.6 K (-0.12 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.12 | 6 | 229 | 149,823 | 149.8 K to 149.8 K (0.00 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Sell | S | 38.13 | 217 | 8,274 | 149,829 | 150 K to 149.8 K (-0.14 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, Chief Financia ... | Payment of Exercise | F | 38.05 | 24,472 | 931,160 | 150,046 | 174.5 K to 150 K (-14.02 %) |
Feb 24 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, & Treasur ... | Option Exercise | M | 24.46 | 35,000 | 856,100 | 70,000 | |
Feb 24 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, & Treasur ... | Sell | S | 37.82 | 3,900 | 147,498 | 174,518 | 178.4 K to 174.5 K (-2.19 %) |
Feb 24 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, & Treasur ... | Sell | S | 37.83 | 6,100 | 230,763 | 178,418 | 184.5 K to 178.4 K (-3.31 %) |
Feb 24 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, & Treasur ... | Sell | S | 37.84 | 13,600 | 514,624 | 184,518 | 198.1 K to 184.5 K (-6.86 %) |
Feb 24 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, & Treasur ... | Sell | S | 37.85 | 11,400 | 431,490 | 198,118 | 209.5 K to 198.1 K (-5.44 %) |
Feb 24 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, & Treasur ... | Buy | M | 24.46 | 35,000 | 856,100 | 209,518 | 174.5 K to 209.5 K (+20.06 %) |
Feb 19 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, Treasurer | Option Exercise | A | 39.00 | 105,000 | 4,095,000 | 105,000 | |
Feb 03 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, and Treas ... | Option Exercise | M | 32.50 | 10,000 | 325,000 | 0 | |
Feb 03 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, and Treas ... | Sell | S | 42.50 | 10,000 | 425,000 | 174,518 | 184.5 K to 174.5 K (-5.42 %) |
Feb 03 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, and Treas ... | Buy | M | 32.50 | 10,000 | 325,000 | 184,518 | 174.5 K to 184.5 K (+5.73 %) |
Jan 16 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, Treasurer | Option Exercise | M | 26.70 | 9,200 | 245,669 | 0 | |
Jan 16 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, Treasurer | Sell | S | 40.00 | 9,200 | 368,000 | 174,518 | 183.7 K to 174.5 K (-5.01 %) |
Jan 16 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, Treasurer | Buy | M | 26.70 | 9,200 | 245,669 | 183,718 | 174.5 K to 183.7 K (+5.27 %) |
Dec 31 2003 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, Treasurer | Option Exercise | M | 26.70 | 9,200 | 245,669 | 9,200 | |
Dec 31 2003 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, Treasurer | Sell | S | 37.50 | 9,200 | 345,000 | 174,360 | 183.6 K to 174.4 K (-5.01 %) |
Dec 31 2003 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, Treasurer | Buy | M | 26.70 | 9,200 | 245,669 | 183,560 | 174.4 K to 183.6 K (+5.28 %) |
Nov 17 2003 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP, CFO, and Treas ... | Sell | S | 35.43 | 1,000 | 35,430 | 174,360 | 175.4 K to 174.4 K (-0.57 %) |
Page: 1